| |
|
This service permits your organization or
association to determine where your anticoagulation
therapy management program ranks compared with others in
this clinical disease area utilizing independent,
impartial data obtained from compatible organizations. |
|
|
The
primary focus of our Benchmarking Service is to provide
a forum for benchmarking of pertinent operational and
clinical performance or outcome measures indicators to
support and enhance the clinical practice of each member
organisation.
It
enables your organization to identify areas for
improvement and provide a means of continuously
monitoring progress in these areas.
We
currently administer a service involving over 30
indicators with over 200,000 patients and some 1,610,000
base measurements each six month period. We operate an
ISO 9001 accredited quality management system for the
design, development, and support of medical database
systems.
The data we collect is patient anonymous.
We are registered as a Data Bureau with the UK Data
Protection Registrar. |
Benefits of the Benchmarking Service
·
Monitoring of key
performance measures
·
Satisfies quality assurance
principles – cannot improve a process until it is measured.
·
Satisfies many internal
audit requirements.
·
Easy production of
statistics that are otherwise time-consuming and complex to
produce.
·
Enables comparison of
performance with other sites
With the site's
permission, issues such as patient education and methods of
giving dosage instruction will be reviewed and if possible
guidelines for best practice produced.
Reports
produced include
·
a comparison of your site
to a summary of all sites participating in a particular run
plus the sites with best and worst performance
·
a review of your site’s
performance through the weeks of a patient’s treatment
Including the statistics for:
·
Number of patients and INRs
for that range/time period
·
% time in, above and below
range using the Rosendaal method
·
% INRs within 0.5 and 0.75
units of the target INR as discussed in
the third edition of the
Guidelines on Oral Anticoagulation (Haemostasis and
Thrombosis Task Force)
Dawn AC
Benchmarking Service
Our benchmarking
service for Dawn AC, has been running for over five years.
Statistics
associated with the previous Dawn AC benchmarking run
·
Over 70 registered sites
·
Over 177,000 patients in
the latest run
·
Over 1,350,000 INRs in the
latest run
·
Currently incorporates over
30 parameters profiling a site’s performance
·
Covers four therapeutic
ranges used for 97% of all patients
How to Participate in the Benchmarking
Service
Data collection occurs twice a year,
covering the periods periods 1st May ~ 31st
October and 1st November ~ 30th April.
Back |
